$NOC

WELSH MARK A III sold $52K of NOC

WELSH MARK A III sold 95 shares of NORTHROP GRUMMAN CORP /DE/ (NOC) at an average of $547.53 ($544.53–$554.14) across 10 trades on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · WELSH MARK A III
Published Aug 4, 2026, 5:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 6:39 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NOC
Neutral
high confidence
Mentioned
$NOC
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NOCNeutralLow
01

Why it matters

The disclosed fact is the sale size, trade date, and post-transaction holdings. It does not include any new guidance, contract award, regulatory action, or earnings datapoint.

02

Market read

Traders may treat this as routine insider activity with low signal value unless it is part of an unusual pattern.

03

What to watch

The article does not disclose whether the sale was part of a broader scheduled selling cadence, nor does it provide options activity or other related insider transactions.

Relevance 2/10Novelty 2/10Timing: filed 2026-08-04, transaction dated 2026-08-03

Background

The article is a SEC Form 4 insider transaction disclosure for Northrop Grumman, reported from an open-market sale by a director under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$NOCNeutralHigh confidence
Context

Northrop Grumman director Mark A. Welsh III sold $52,014.91 of NOC shares via an open-market sale under a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term impact; any effect is likely sentiment-only and should fade unless follow-on filings show unusual selling.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, and the article provides no new company-specific operational or financial information.

Market effects

Defense primes may see periodic insider 10b5-1 sales without signaling program or margin changes.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, clustered insider selling can sometimes coincide with private views on valuation or timing, so traders may watch for additional Form 4 sales.

Key entities

  • NORTHROP GRUMMAN CORP /DE/

    Subject of the Form 4 insider sale disclosure.

  • WELSH MARK A III

    Director who executed the open-market sale under a 10b5-1 plan.

Related articles

$NOCMed

The Pentagon is urging defense contractors to urgently ramp up weapons production – WP

The U.S. Department of Defense, according to The Washington Post, asked defense contractors to submit within 21 days production and delivery schedules for critical systems, citing depleted stockpiles. CSIS estimates cite heavy early use of missiles and falling Patriot and THAAD inventories. The Pentagon is working with Northrop Grumman and Lockheed Martin, including a $58.6B deal to triple PAC-3 output by 2030, pending a stalled $1.15T defense budget.

$LMTMed

Pentagon pushes military contractors to accelerate production amid shortages after war on Iran

The Pentagon ordered US defense contractors to submit within 21 days plans to accelerate production of missiles and interceptors amid shortages after the first month of strikes against Iran. It cited depleted Patriot and THAAD inventories and said framework agreements with Lockheed Martin and Northrop Grumman target PAC-3 and THAAD output. Lockheed Martin received a contract up to $58.6B to triple PAC-3 production by 2030.

$NOCMed

WP: Pentagon asks defense companies to urgently ramp up weapons production

The Pentagon, via Deputy Secretary Steve Feinberg, urged U.S. defense firms to accelerate weapons output, especially ammunition, and asked executives to submit production and delivery plans within 21 days, according to The Washington Post. CSIS data cited Patriot and THAAD stockpiles falling sharply. The article notes talks with Northrop Grumman and Lockheed Martin and a Lockheed contract up to $58.6B to triple PAC-3 output by 2030.

$RTXMedAI 8/10

Pentagon warns arms makers to accelerate output as U.S. munitions crisis grows

The Pentagon, according to a memo reported by The Washington Post and confirmed by spokesman Sean Parnell, is urging defense contractors to accelerate production of critical munitions within 21 days, citing rapid U.S. missile and interceptor usage in the Iran war. CSIS estimates Patriot and THAAD stocks fell sharply. The memo also ties plans to shaping the fiscal 2028 defense budget.

$RKLBMedAI 8/10

Pentagon Awards More Space-Based Airborne Target Tracking Contracts

The U.S. Space Force awarded $615 million across three contracts to develop space-based airborne moving target indicator (AMTI) capabilities, citing supplier diversification and different sensing technologies. Rocket Lab and STR were named, and a third contractor was undisclosed for operational security. The awards follow a May $4.16 billion SpaceX contract for an initial AMTI constellation by 2028.

$NOCMed

DOW Signs $3B in PAC-3, THAAD Production Deals With Northrop

The U.S. Department of War (DOW) signed two framework agreements with Northrop Grumman totaling over $3 billion, coordinated with Lockheed Martin, to expand production for PAC-3 MSE and THAAD components. DOW said the deals will triple PAC-3 MSE and quadruple THAAD component output, including solid rocket motors and structural parts, over seven years.